BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12021350)

  • 1. The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo.
    Teng MN; Collins PL
    J Virol; 2002 Jun; 76(12):6164-71. PubMed ID: 12021350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.
    Teng MN; Whitehead SS; Collins PL
    Virology; 2001 Oct; 289(2):283-96. PubMed ID: 11689051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains.
    Lee J; Klenow L; Coyle EM; Golding H; Khurana S
    PLoS Pathog; 2018 Aug; 14(8):e1007262. PubMed ID: 30142227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus.
    Langedijk JP; Schaaper WM; Meloen RH; van Oirschot JT
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1249-57. PubMed ID: 8683213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor.
    Langedijk JP; de Groot BL; Berendsen HJ; van Oirschot JT
    Virology; 1998 Apr; 243(2):293-302. PubMed ID: 9568029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein.
    Elliott MB; Pryharski KS; Yu Q; Boutilier LA; Campeol N; Melville K; Laughlin TS; Gupta CK; Lerch RA; Randolph VB; LaPierre NA; Dack KM; Hancock GE
    J Virol; 2004 Aug; 78(16):8446-54. PubMed ID: 15280453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse.
    Bukreyev A; Whitehead SS; Murphy BR; Collins PL
    J Virol; 1997 Dec; 71(12):8973-82. PubMed ID: 9371553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein.
    Plotnicky-Gilquin H; Goetsch L; Huss T; Champion T; Beck A; Haeuw JF; Nguyen TN; Bonnefoy JY; Corvaïa N; Power UF
    J Virol; 1999 Jul; 73(7):5637-45. PubMed ID: 10364313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.
    Green G; Johnson SM; Costello H; Brakel K; Harder O; Oomens AG; Peeples ME; Moulton HM; Niewiesk S
    J Virol; 2021 Jul; 95(16):e0001021. PubMed ID: 34037420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.
    Karron RA; Buonagurio DA; Georgiu AF; Whitehead SS; Adamus JE; Clements-Mann ML; Harris DO; Randolph VB; Udem SA; Murphy BR; Sidhu MS
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13961-6. PubMed ID: 9391135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
    Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
    Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of altering the transcription termination signals of respiratory syncytial virus on viral gene expression and growth in vitro and in vivo.
    Tran KC; Collins PL; Teng MN
    J Virol; 2004 Jan; 78(2):692-9. PubMed ID: 14694100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment.
    Plotnicky-Gilquin H; Robert A; Chevalet L; Haeuw JF; Beck A; Bonnefoy JY; Brandt C; Siegrist CA; Nguyen TN; Power UF
    J Virol; 2000 Apr; 74(8):3455-63. PubMed ID: 10729118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant respiratory syncytial virus with the G and F genes shifted to the promoter-proximal positions.
    Krempl C; Murphy BR; Collins PL
    J Virol; 2002 Dec; 76(23):11931-42. PubMed ID: 12414935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity and structural characteristics of the nonglycosylated central subdomain of human respiratory syncytial virus attachment (G) glycoprotein.
    Gorman JJ; McKimm-Breschkin JL; Norton RS; Barnham KJ
    J Biol Chem; 2001 Oct; 276(42):38988-94. PubMed ID: 11487583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Stability of Parainfluenza Virus 5-Vectored Human Respiratory Syncytial Virus Vaccine Candidates after
    Phan SI; Adam CM; Chen Z; Citron M; Liang X; Espeseth AS; Wang D; He B
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28747497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection.
    Schlender J; Zimmer G; Herrler G; Conzelmann KK
    J Virol; 2003 Apr; 77(8):4609-16. PubMed ID: 12663767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein.
    Meng J; Hotard AL; Currier MG; Lee S; Stobart CC; Moore ML
    J Virol; 2016 Jan; 90(1):245-53. PubMed ID: 26468535
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Rijsbergen LC; Rennick LJ; Laksono BM; van Run PRWA; Kuiken T; Duprex WP; de Swart RL; de Vries RD
    J Gen Virol; 2020 Oct; 101(10):1037-1046. PubMed ID: 32692644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo.
    Hickling TP; Bright H; Wing K; Gower D; Martin SL; Sim RB; Malhotra R
    Eur J Immunol; 1999 Nov; 29(11):3478-84. PubMed ID: 10556802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.